Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Donor HLA genotyping of ex vivo expanded urine cells from kidney transplant recipients.

HLA - 1 Nov 2021

Li Xirui, Wei Yongcheng, Li Jun, Deng Ronghai, Fu Qian, Nie Weijian, Zhang Huanxi, Wu Chenglin, Su Xiaojun, Wang Jiali, Cao Dajiang, Liu Xiangjun, Liu Longshan, Wang Changxi

Abstract excerpt

Antibody-mediated rejection (AMR) induced by donor-specific anti-HLA antibodies (DSA) remains a major cause of long-term graft loss after kidney transplantation. Currently, the presence of DSA cannot always be determined at a specific allele level, because existing donor HLA typing is low resolution and often incomplete, lacking HLA-DP, and occasionally HLA-C and HLA-DQ information and historical donor DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Graft Rejection

Share to Histocompatibility Testing

Share to HLA Antigens

Share to Kidney Transplantation

Share to Tissue Donors

Share to Transplant Recipients

Source

Identifiers

PMID: 34505410
DOI: 10.1111/tan.14426

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor HLA genotyping of ex vivo expanded urine cells from kidney transplant recipients.PMID 34505410Read ↗

A Modified Protocol with Improved Detection Rate for Mis-Matched Donor HLA from Low Quantities of DNA in Urine Samples from Kidney Graft Recipients.Semantic proximity Read ↗

Deep sequencing of DNA from urine of kidney allograft recipients to estimate the donor-specific DNA fractionSemantic proximity Read ↗

Quantifying donor-recipient mismatches using recipient-derived sources of donor DNASemantic proximity Read ↗

Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation.Semantic proximity Read ↗

Clinical Applicability of 2-Field High-Resolution and Extended HLA-Allele Typing in Deceased Donor Kidney Allocation.Semantic proximity Read ↗

Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNASemantic proximity Read ↗

Persistently Elevated Donor-Derived Cell-Free DNA After Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Preliminary Observational StudySemantic proximity Read ↗

Detection of donor-derived cell-free DNA in the setting of multiple kidney transplantationsSemantic proximity Read ↗

Comparison of Methods for Donor-Derived Cell-Free DNA Quantification in Plasma and Urine from Solid Organ Transplant RecipientsSemantic proximity Read ↗

Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipientsSemantic proximity Read ↗

Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft InjuriesSemantic proximity Read ↗

Incidence and impact of allele-specific anti-HLA antibodies and high-resolution HLA genotyping on assessing immunologic compatibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.